Back to Search
Start Over
Table S1 and Table S2 from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Table S1: BROCA-HR gene list Table S2: Best Response, TTP, OS in Patients with HR-DDR Defects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2aa7244ad887ba1c96708f23ce42ce3e
- Full Text :
- https://doi.org/10.1158/1078-0432.22483595